Experts in translational oncology and targeted protein degradation join Dr Simon Cook, Dr Lorenz Mayr and Dr Catherine Beech to provide scientific and strategic oversight
News
Anglia Ruskin University (ARU) and Writtle University College are delighted to announce a proposal to merge the two institutions.
The proposed merger will secure a long-term, sustainable future for Writtle, and unlock significant opportunities for growth and development by bringing together the two institutions’ strengths across education and research.
Now in its 130th year and located on the outskirts of Chelmsford, Writtle University College is one of the UK’s leading institutions for land-based studies.
Leading science and innovation campus, Discovery Park, in Sandwich, Kent has launched a new business support programme and competition, ‘Discovery Spark’. The programme will lay healthy foundations for future company success and equip early stage life science businesses with the skills needed when pitching to investors.
Click here to view the July 2023 edition of The Meeting Place!
In this short video, Mike Davies, CEO of Carocell Bio, shares insights into their fascinating technology and how it could improve the lives of patients with anti-inflammatory peptides applied topically to the skin. This approach has great potential to treat and prevent the recurrence of eczema and has potential anti-ageing properties.
Scaling up – how space is the key ingredient to superpower status
Domainex significantly expands its footprint, leasing the first of three new laboratory buildings at Unity Campus
Edinburgh and Cambridge, UK, 7 July 2023 - Macomics Ltd, a leader in macrophage drug discovery, is delighted to announce that it was voted as the winner of the 2023 BioNewsRound Award for the news of its worldwide drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd.
Dr Stevens promoted from Director of Drug Discovery, and Dr Kirby promoted from Director of Operations
Cambridge, UK, 06 July 2023: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointments of Dr Robert Kirby to Chief Operating Officer and Dr Edward Stevens to Chief Scientific Officer. Both appointments represent promotions from within the company.
Life Sciences industry entrepreneur joins the region’s Life Science & Healthcare membership organisation